FENOCIPLA, FENOCOL, FENOFIBRATE CIPLA (Cipla Australia Pty Ltd)
Product name
FENOCIPLA, FENOCOL, FENOFIBRATE CIPLA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
156 working days (255)
Active ingredients
fenofibrate
Registration type
New generic medicine
Indication
FENOCIPLA, FENOCOL, FENOFIBRATE CIPLA (tablet) is indicated as an adjunct to diet in the treatment of:
- hypercholesterolaemia;
- types II, III, IV and V dyslipidaemia;
- dyslipidaemia associated with type 2 diabetes.